Drug
Metvix
Metvix: highest development phase Phase 3, developed by Galderma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Galderma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Metvix® cream NCT00469417 | Phase 3 | Superficial Basal Cell Carcinoma |
Latest
No recent events.
Follow Metvix on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.